LEADING INDUSTRY EXPERTS AND INVESTORS TO OUTLINE UNIQUE OPPORTUNITIES IN NF RESEARCH
NEW YORK, N.Y., June 9, 2014 — The Children’s Tumor Foundation (CTF) is hosting the 2014 NF Conference, the largest worldwide meeting dedicated entirely to neurofibromatosis (NF), a genetic disorder that affects one in 3,000 people and can cause tumors to grow anywhere in the body. Media is invited to cover a unique ‘satellite meeting’ taking place concurrently with the NF Conference.
“INNOVATIVE BUSINESS OPPORTUNITIES IN NF”
What : Business satellite meeting outlining innovative opportunities for NF, including a presentation of the NF market model
Who : Biotech and pharma executives; leading scientific research advocates; scientists/researchers
INDUSTRY PANEL SPEAKING AT THE MEETING:
Randall Stanicky , RBC Managing Director, Global Equity Research – Specialty Pharmaceuticals
David Lapidus , Principal, LapidusData
Mark DeSouza , PhD, CEO, desouzatech
Margaret Anderson , Executive Director, FasterCures
Scott Plotkin , MD, PhD, Director NF Clinic, Massachusetts General Hospital
Gideon Bollag , PhD, CEO,Plexxikon
Sara Nayeem , MD, Principal, New Enterprise Associates
Isai Peimer , Principal, MedImmune Ventures
Where: Omni Shoreham Hotel in Washington, DC
When: Monday, June 9 at 2PM
Media Opportunity: Coverage of meeting and interviews with the panelists
The annual NF Conference is the premier event in the neurofibromatosis research and clinical calendar. The theme for this year’s Conference is “Connecting for a Cure,” which reflects the event’s impressive gathering of clinicians, researchers, and scientists from many different ‘classical’ disease areas, including genetics, neurology, oncology, pediatrics, neurosurgery, orthopedics, and many others. It is an opportunity to share information and build relationships, driven by the goal of ending NF.
Media is invited to attend any portion of the conference. To see a complete agenda, visit:
www.ctf.org/nfconference
To attend the “Innovative Business Opportunities in NF’ meeting, please contact Simon Vukelj, Director of Communications, Children’s Tumor Foundation;
svukelj@ctf.org
212-344-7568
